SCHEMBL19082215

SCHEMBL19082215

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(c4)sc4cc6c(cc45)sc4cc5ccccc5cc46)cc3)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.44
ESR2 Q92731 9/20 0.44
LIMK1 P53667 1/20 0.39
PIK3CA P42336 1/20 0.39
PI4KA P42356 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
MCL1 Q07820 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
F9 P00740 2/20 0.36
GPR3 P46089 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B1 P14061 1/20 0.33
CYP2B6 P20813 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944768 0.98 ESR1 (0.45) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17247101 0.95 ESR1 (0.45) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17944516 0.95 ESR1 (0.45) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17247125 0.94 ESR1 (0.42) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17246875 0.94 ESR1 (0.46) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17247129 0.93 ESR1 (0.43) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17944896 0.93 ESR1 (0.43) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17247122 0.93 ESR1 (0.40) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17943964 0.93 ESR1 (0.40) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL17247105 0.93 ESR1 (0.40) ESR1ESR2LIMK1PIK3CAPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.